Key result
Recombinant Ang-2 treatment significantly impaired blood flow recovery and reduced collateral arteriole diameter in a mouse model of hindlimb ischaemia.
Why the study?
Does recombinant Angiopoietin-2 impair collateral artery growth and blood flow recovery in a mouse model of hindlimb ischaemia?
Does recombinant Angiopoietin-2 impair collateral artery growth and blood flow recovery in a mouse model of hindlimb ischaemia?
In a mouse model of hindlimb ischaemia, Angiopoietin-2 impairs collateral artery growth and blood flow recovery by suppressing macrophage infiltration and downregulating angiogenic factors.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice; hypothesis-generating for Ang-2 targeting to promote arteriogenesis in ischaemia.
BACKGROUND: Angiopoietin-2 (Ang-2), a ligand of the Tie-2 receptor, plays an important role in maintaining endothelial cells and in destabilizing blood vessels. Collateral artery growth (arteriogenesis) is a key adaptive response to arterial occlusion. It is unknown whether the destabilization of blood vessels by Ang-2 can affect arteriogenesis and modulate mononuclear cell function. This study aimed to investigate the effects of Ang-2 on collateral artery growth. METHODS: Hindlimb ischaemia model was produced in C57BL/6 mice by femoral artery ligation. Blood flow perfusion was measured using a laser Doppler perfusion imager quantitative RT-PCR analysis was applied to identify the level of angiogenic factors. RESULTS: After the induction of hindlimb ischaemia, blood flow recovery was impaired in mice treated with recombinant Ang-2 protein; this was accompanied by a reduction of peri-collateral macrophage infiltration. In addition, quantitative RT-PCR analysis revealed that Ang-2 treatment decreased monocyte chemotactic protein-1 (MCP-1), platelet-derived growth factor-BB (PDGF-BB) mRNA levels in ischaemic adductor muscles. Ang-2 can lead to macrophage M1/M2 polarization shift inhibition in the ischaemic muscles. Furthermore, Ang-2 reduced the in vitro inflammatory response in macrophages and vascular cells involved in arteriogenesis. CONCLUSIONS: Our results demonstrate that Ang-2 is essential for efficient arteriogenesis, which controls macrophage infiltration.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2016) studied Hindlimb ischaemia. Recombinant human Ang-2 vs. Vehicle (PBS) was evaluated on Blood flow recovery (ratio of ischaemic to non-ischaemic hindlimb blood flow) (p=<0.05). Recombinant Ang-2 treatment significantly impaired blood flow recovery and reduced collateral arteriole diameter in a mouse model of hindlimb ischaemia.
Synapse has enriched 10 related papers. Consider them for comparative context: